C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
By John Danesh, J. Wheeler, Gideon M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. Lowe, M. Pepys, V. Gudnason. New England Journal of Medicine, 2004
3,082 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/88abfe57e6e4ec76d7b342da1a0e05e31318db33
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Peter Libby
- P. Ridker
- G. Hansson
- Alberico L. Catapano
- I. Graham
- Lina Badimon
- Diederick E. Grobbee
- Rhian M. Touyz
In Immunology
- Peter Libby
- P. Ridker
- G. Hansson
- Alberico L. Catapano
- Lina Badimon
- Andrew Steptoe
- Rhian M. Touyz
- I. Tabas
In Oncology
Citations in the corpus
- The effects of acute psychological stress on circulating and stimulated inflammatory markers: A systematic review and meta-analysis (2017, background): “…increases in inflammatory mediators in response to acute stress have higher tonic levels of systemic inflammation that are known to predict future risk for cardiovascular disease (Danesh et al, 2004; Hennekens, Buring, Rifai, 2000; Ridker, Rifai, Stampfer, Hennekens, 2000; Ridker et al., 2000).”
- Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. (2007, neutral): “Andresdottir, 2003 (27); Danesh, 2004 (28); Saevarsdottir, 2005 (29) Inflammation”
- Which white blood cell subtypes predict increased cardiovascular risk? (2005, background): “Of these proposed inflammatory markers, C-reactive protein (CRP) has been the most extensively studied and clinically applied to date; however, its value as a predictor of risk has recently been questioned ( 10 ,11), and the need to develop and apply additional complementary inflammatory markers of ”
- C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. (2007, neutral): “The investigators of the Reykjavik Heart Study did not report outcomes by hsCRP levels of (cid:1) 1 mg/l, 1 to 3 mg/l, and (cid:2) 3 mg/l, but did report multivariate adjusted evidence showing that individuals with hsCRP in the highest tertile were significantly more likely to suffer future vascular ”
- The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. (2009, result): “The overall size of associations between anger/hostility and CHD outcomes might seem small; however, it is worth pointing out that this effect size is not markedly different from many others identified in prospective observational epidemiological research ( 82 ).”
- The immune response in atherosclerosis: a double-edged sword (2006, background): “Lesser elevations of CRP concentration, measured with a highly sensitive assay and previously considered in the 'normal range,' can be used to predict cardiovascular events in apparently well population”